Veritas In Silico is a research and sales of pharmaceuticals firm that offers drug discovery platform technology with scientific evidences.
Veritas In Silico's investors include Mitsubishi UFJ Capital, Mizuho Capital, SMBC Venture Capital, Global Brain Corporation, Nippon Venture Capital.
Veritas In Silico is headquartered in Tokyo, Japan.
Veritas In Silico is a research and sales of pharmaceuticals firm that offers drug discovery platform technology with scientific evidences.
Veritas In Silico is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Veritas In Silico — Funding & Investors." VCBacked, December 27, 2021, https://www.vcbacked.co/company/veritas-in-silico. Accessed September 30, 2026.
VCBacked. (2021). Veritas In Silico — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/veritas-in-silico
{{cite web |title=Veritas In Silico — Funding & Investors |url=https://www.vcbacked.co/company/veritas-in-silico |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated